FoRx Therapeutics is a privately held clinical-stage biotechnology company pioneering precision therapeutics targeting the DNA Damage Response in treatment-resistant cancers. Its lead product ...
The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, reports that it has suffered ...
Paris, France and London, United Kingdom (18 December 2025) – EssilorLuxottica and Burberry today announced the renewal of their licensing agreement for the development, production and global ...
Sofio uses patented magnetohydrodynamics (MHD) to draw a micro-sample of interstitial fluid through skin, where glucose is measured using established glucose oxidase enzyme chemistry, the same method ...
Paris, France et Londres, Royaume-Uni (18 décembre 2025) – EssilorLuxottica et Burberry ont annoncé aujourd’hui le renouvellement de leur accord de licence pour la conception, la production et la ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback